This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Huntsman, Clariant abandon $20 billion merger amid opposition

( October 27, 2017, 07:32 GMT | Official Statement) -- MLex Summary: Chemical makers Huntsman and Clariant have agreed to cancel their proposed $20 billion merger, bowing to opposition from activist investors. The companies said they remained convinced that the deal was in the best interests of their shareholders. But the “accumulation of shares by activist investor White Tale Holding” and support from other investors had injected too much uncertainty into whether Clariant could secure shareholder approval for the deal, they said.Full statement follows:  ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login